Metrics as of 10/13/2026, 06:51 PM (Berlin time), refresh in progress.
Mobia Medical Stock
Mobia Medical, Inc. Common Stock
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Richard Foust
- Employees
- 167
- Market cap
- $286 M
- IPO
- 08/05/2026
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological…
Mobia Medical stock: price history
1D
+0.2%
1W
-2.0%
1M
-13.9%
6M
–
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Mobia Medical
Analyst assessment of Mobia Medical
PRICE TARGET LOW
US$19.00
CONSENSUS
US$25.00
MEDIAN
US$25.00
PRICE TARGET HIGH
US$31.00
No current analyst ratings available.
Mobia Medical stock metrics
P/E
-5.25
P/B
0.95
EV/EBITDA
-3.35
RETURN ON EQUITY
-12.2%
NET MARGIN
-155.8%
DEBT/EQUITY
0.05
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
6.2%
FLOAT SHARES
2,056,918
AVG. DAILY VOLUME (30D)
255,206
Insider transactions (SEC)
Leavitt Chase C.
Rawat Prashant B.
Tansey Casey M
Tansey Casey M
Tansey Casey M
Institutional holders
Comparable stocks
Frequently asked questions about Mobia Medical stock
What does Mobia Medical do?
Mobia Medical, Inc. Common Stock is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Richard Foust, the company employs around 167 people.
The IPO was on 08/05/2026; the stock trades on NASDAQ under the ticker MOBI.
What do analysts say about Mobia Medical stock?
The average price target is US$25.00, ranging from US$19.00 to US$31.00, with a median of US$25.00.
This is an external assessment, not a statement by Market Jury.
Does Mobia Medical pay a dividend?
No, Mobia Medical currently does not pay a dividend.
Which stocks are comparable to Mobia Medical?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get Mobia Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Mobia Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.